KT&G Appoints New President: Transforming into Global Leader

News by 2FIRSTS.ai
Apr.01.2024
KT&G Appoints New President: Transforming into Global Leader
KT&G Appoints New CEO in First Leadership Change in Nine Years, Promising Global Expansion and Enhanced Stakeholder Trust.

Recently, according to Naver news, KT&G has replaced its CEO for the first time in nine years. The longtime CEO, Baek Bok-in, stepped down after serving three consecutive terms and was succeeded by senior vice president Bang Kyung-man. During the shareholders' meeting, Bang Kyung-man defeated Sun Dong-hwan, a law professor at Sungkyunkwan University, who received 56.6 million votes, as well as KT&G board chairman Im Min-kyu, who received 24.5 million votes, garnering 84.09 million votes.

 

As the head of the global headquarters, Bang Kyung-man increased the number of countries to which KT&G products are exported from 40 to over 100, with overseas sales exceeding 1 trillion Korean won. Within the company, he is highly praised for leading the development of medium to long-term strategies centered around three core businesses (overseas cigarettes, e-cigarettes, and health functional foods). A KT&G official said, "His high vote of confidence at the shareholders' meeting indicates that he is widely recognized as the right person to lead KT&G.

 

After the shareholders' meeting, Bang Kyung-man immediately stated that his goal is to "use the three core businesses as a springboard for development, leap towards becoming a world-class company", and to "share development achievements, increase company value, and establish stronger trust with all stakeholders, including shareholders." He proposed the "T-O-P" management strategy, which aims to improve trust with stakeholders through active communication, ensure competitiveness in the original location, and strengthen global specialization.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20
Russia’s Federation Council Approves Ban on Vape and Cigarette Sales at Transport Stops
Russia’s Federation Council Approves Ban on Vape and Cigarette Sales at Transport Stops
Russia’s Federation Council has approved a law banning the sale of all nicotine-containing products, including cigarettes and e-cigarettes, at urban and suburban public transport stops. The law includes an exemption for cases where a retail outlet at a stop is the only point of sale in a locality. The legislation will come into force on September 1, 2026.
Dec.19 by 2FIRSTS.ai
Japan Tobacco Unveils New Ploom EVO Honey Lemon Smoke Stick, Nationwide Launch in Japan from January 2026
Japan Tobacco Unveils New Ploom EVO Honey Lemon Smoke Stick, Nationwide Launch in Japan from January 2026
Japan Tobacco (JT) has announced a new flavor for its Ploom brand’s premium EVO smoke sticks: “EVO Honey Lemon Crystal.” The product will be rolled out in stages, beginning with an early release through official channels in December 2025, followed by a nationwide launch across convenience stores and tobacco retailers in January 2026, priced at JPY 550 (approximately USD 3.7).
Dec.16 by 2FIRSTS.ai
BAT Taps McLaren Title Win for Travel Retail Activation, Launches VELO “Champions’ Edition” Nicotine Pouches
BAT Taps McLaren Title Win for Travel Retail Activation, Launches VELO “Champions’ Edition” Nicotine Pouches
British American Tobacco (BAT) is leveraging McLaren F1 Team’s 2025 Constructors’ Championship win to roll out a VELO×McLaren brand activation across the travel retail market. The campaign spans major airports in Abu Dhabi, the UK, Ireland and Spain, alongside the launch of a VELO “Champions’ Edition” product.
Dec.15 by 2FIRSTS.ai
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak executive councillor Datuk Sivanesan said the state government aims to progressively reach a “zero” level of vape sales no later than after October, noting vape operators were clearly informed in October 2025.
Jan.05 by 2FIRSTS.ai